Previous Close | 1.1600 |
Open | 1.1600 |
Bid | 1.1300 x N/A |
Ask | 1.1700 x N/A |
Day's Range | 1.1300 - 1.1800 |
52 Week Range | 0.6400 - 8.0000 |
Volume | |
Avg. Volume | 51,582 |
Market Cap | 41.572M |
Beta (5Y Monthly) | 1.83 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BRIACELL THERAP (BCTX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BriaCell Therapeutics Announces US$8.5 Million Share Offering